ARS Pharmaceuticals, Inc (SPRY) — Net Asset Quality Index
ARS Pharmaceuticals, Inc (SPRY) has a Net Asset Quality Index of 34.9% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $327.65 Million minus total liabilities of $213.39 Million yields net assets of $114.26 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read debt load of ARS Pharmaceuticals, Inc for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
ARS Pharmaceuticals, Inc Net Asset Quality Index Over Time (2018–2025)
This chart shows how ARS Pharmaceuticals, Inc's Net Asset Quality Index has evolved across 8 annual periods from 2018 to 2025. As of December 2025, the index stands at 34.9%, representing net assets of $114.26 Million against total assets of $327.65 Million USD. For live market cap and overall valuation, see market cap of ARS Pharmaceuticals, Inc.
Annual Net Asset Quality Index for ARS Pharmaceuticals, Inc (2018–2025)
The table below presents the year-by-year Net Asset Quality Index for ARS Pharmaceuticals, Inc from 2018 to 2025, covering 8 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check ARS Pharmaceuticals, Inc strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 34.9% | $114.26 Million | $327.65 Million | $213.39 Million | ▼ -38.3 pp |
| 2024 | 73.1% | $256.80 Million | $351.15 Million | $94.36 Million | ▼ -25.8 pp |
| 2023 | 99.0% | $230.76 Million | $233.19 Million | $2.43 Million | ▲ +2.0 pp |
| 2022 | 97.0% | $272.89 Million | $281.44 Million | $8.55 Million | ▲ +147.9 pp |
| 2021 | -50.9% | $-31.27 Million | $61.45 Million | $92.72 Million | ▲ +2.3 pp |
| 2020 | -53.2% | $-14.05 Million | $26.41 Million | $40.46 Million | ▼ -17.4 pp |
| 2019 | -35.8% | $-5.60 Million | $15.65 Million | $21.25 Million | ▼ -101.9 pp |
| 2018 | 66.1% | $18.20 Million | $27.55 Million | $9.35 Million | — |